Article Topic
Four things Congress should do for patient safety in the rest of the 119th
This post outlines practical steps Congress should take to strengthen pharmaceutical border security, reinforce regulatory oversight, and protect patients.
[...]February 2, 2026: Med spa owner charged with posing as a registered nurse
A patient at a North Dakota med spa told investigators she had to coach the clinic owner through the IV administration process. The owner allegedly presented herself as a registered nurse, despite holding no medical licenses.
[...]Prescription Drug Affordability Board Activity, December 2025
Prescription Drug Affordability Board Activity, December 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on December 8, 2025 to review…
[...]PSM endorses Iowa HSB 591 to strengthen med spa oversight for Iowans
The bill will protect Iowa’s patients by closing enormous regulatory gaps in the med spa and wellness industry.
[...]In July, Google promised to rid their platform of criminals selling pill presses. How’s it going?
As of the first week of January, we found several companies with multiple ads still running well past its self-imposed deadline. Google can do better, but will they?
[...]FDA Alert: Supplements with undeclared drug ingredients
The FDA has posted notices for two nationwide dietary supplement recalls involving products found to contain undeclared pharmaceutical ingredients.
[...]Prescription Drug Affordability Board Activity, November 2025
Prescription Drug Affordability Board Activity, November 2025 Activities Summary Colorado: In October, Colorado’s PDAB heard testimony about its decision to set an upper payment limit on Enbrel, and set price of $600 per 50mg/1ml, effective January 1, 2027. The board’s next meeting is January 9, 2026. Maryland:The PDAB met on November 17, 2025 where they…
[...]Intelligence Alert: Unlicensed med spas are selling unregulated diabetes and weight loss injectables that threaten public safety
Based on recent investigative reporting by the Partnership for Safe Medicines (PSM), patients in your state may be receiving weight loss injectables from unlicensed sources that do not meet FDA requirements for safety and sterility. PSM has established a dedicated contact from CBP/HSI to support investigations by state law enforcement on this issue.
[...]December 15, 2025: A Massachusetts man will plead to giving botulism-causing injections, says the U.S. Attorney’s Office
The med spa owner admitted to using unapproved injectables that sickened at least 10 patients. New York authorities announced the results of a 2024 crackdown on illegal med spas. PSM published in The Journal of Illicit Trade, Financial Crime, and Compliance.
[...]PSM urges the House Energy & Commerce Committee to support the SAFE Drugs Act of 2025
PSM wrote the House Energy & Commerce Committee in support of the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act, to help protect the American drug supply from unsafely compounded medication.
[...]